Navigation Links
Sentrx Growth Continues with Four New Clients in Second Quarter
Date:7/31/2008

Sentrx, a leading provider of drug safety services, gained four new contracts in the second quarter, including a risk evaluation and mitigation strategy (REMS). The company was also awarded a significant contract expansion.

Little Falls, NJ (PRWEB) July 31, 2008 -- Sentrx, a leading provider of http://www.sentrx.com/drug_safety_services.shtml [drug safety __title__ drug safety] services, announced today that the company signed four new multi-year contracts in the second quarter of 2008. Combined with wins from the first quarter, Sentrx gained nine clients in the first six months of 2008.

Sentrx pioneered the concept of http://www.sentrx.com/drug_safety_services.shtml [drug safety __title__ drug safety] outsourcing for clinical trial safety monitoring, post-marketing safety surveillance, and risk management programs. The multi-year contracts initiated in the second quarter of 2008 include:

  • A risk evaluation and mitigation strategy (REMS) for a biopharmaceutical company
  • Post-marketing safety surveillance with managed safety system hosting for a specialty pharmaceutical company
  • Clinical trial safety monitoring with managed safety system hosting for two biopharmaceutical companies
In addition to the new contracts, Sentrx was awarded a significant contract expansion from an existing large biopharmaceutical client. Sentrx will perform adverse event case processing for additional post-marketed products, doubling the volume of work in 2008.

Sentrx went live with one of the first FDA-required REMS implementations in July, meeting the client's extremely tight timeframe for successful product launch. The Sentrx SafetyTrak® Technology Suite was configured to create a controlled distribution program, ensuring that only registered hospitals order and receive the new drug. Health care professionals in the Sentrx Safety Response Center register hospitals that wish to utilize the treatment in certain post-surgical patients.

"Our second quarter results contain more than one milestone. Besides supporting one of the first REMS, Sentrx will be implementing its first Empirica(tm) Trace instance for a client, making us the only drug safety services provider to offer a choice of http://www.sentrx.com/consulting.shtml [pharmacovigilance __title__ pharmacovigilance] systems," said Joseph Albano, Chief Executive Officer of Sentrx. "Our unique blend of information technology talent, operational excellence and good clinical practices continues to meet the needs of the biopharmaceutical market."

About Sentrx:
Sentrx is a leading provider of technology-enabled solutions and services for global drug safety. Its mission is to help pharmaceutical, biotechnology, medical device, and consumer health companies document the safety profile of their products during clinical development and post-approval, enabling them to minimize risks and maximize benefits. Through its multilingual Safety Response Center, Sentrx delivers a unique combination of highly skilled people, exclusive technology, and best practices in drug safety monitoring. To learn more about Sentrx, please call 1-888-399-8032, extension 261, or click here for a short movie: (www.sentrx.com/impactmovie).
        
Media Contact:
Jill Notte
Executive Director, Marketing
150 Clove Road
Little Falls, NJ 07424
1-973-812-7575 ext. 261
http://www.sentrx.com

Read the full story at http://www.prweb.com/releases/2008/07/prweb1164594.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Explosive Growth in Medical Tourism and Rise of Retail Clinics Provide Huge Cost Savings for Patients
2. FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008
3. Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income
4. VNUS Medical Technologies Reports Second-Quarter 2008 Results: 25% Growth in Net Product Revenues and 38% Growth in Unit Sales
5. Ingenious Med Continues Record Customer Growth and Approaches Key Milestones
6. Southern Home Medicals Encore Medical Staffing Division Poised to Benefit from Major Growth in Nursing Industry
7. Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance
8. Perrigo Company to Present at The Oppenheimer & Co. Inc. 8th Annual Consumer Growth Conference
9. Thermage, Inc. to Present at the Fourth Annual Collins Stewart Growth Conference
10. Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference
11. Sunesis Pharmaceuticals to Present at the Collins Stewart Fourth Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sentrx Growth Continues with Four New Clients in Second Quarter
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the ... (United States, China, Japan, Brazil, United Kingdom, Germany, France, ... Surgical Procedure Volumes: ... provides surgical procedure volume data in a geographic context. ... analysis of growth drivers and inhibitors, including world population ...
(Date:6/23/2016)... , June 23, 2016 ... but it continues to present great opportunities to investors. ... for today: Intrexon Corp. (NYSE: XON ), ... Pharmaceuticals Inc. (NASDAQ: ARNA ), and Regeneron ... about these stocks and receive your complimentary trade alerts ...
(Date:6/23/2016)... SAN DIEGO , June 23, 2016 /PRNewswire/ ... advancing programs that address medical conditions resulting from ... that it has appointed Greg Doyle ... member of Leading BioSciences, executive management team and ... officer and chief financial officer. He will provide ...
Breaking Medicine Technology: